REGENXBIO Inc. (RGNX)
NASDAQ: RGNX
· Real-Time Price · USD
10.43
-0.15 (-1.42%)
At close: Oct 03, 2025, 3:59 PM
10.57
1.34%
After-hours: Oct 03, 2025, 05:46 PM EDT
-1.42% (1D)
| Bid | 9.85 |
| Market Cap | 526.86M |
| Revenue (ttm) | 155.78M |
| Net Income (ttm) | -175.57M |
| EPS (ttm) | -3.48 |
| PE Ratio (ttm) | -3 |
| Forward PE | -5.04 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.45 |
| Volume | 656,789 |
| Avg. Volume (20D) | 588,396 |
| Open | 10.58 |
| Previous Close | 10.58 |
| Day's Range | 10.42 - 10.98 |
| 52-Week Range | 5.04 - 12.22 |
| Beta | 1.17 |
| Ex-Dividend Date | n/a |
About RGNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RGNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RGNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsREGENXBIO Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-17.06%
Regenxbio shares are trading lower after the compa...
Unlock content with
Pro Subscription
4 months ago
+2.63%
RGNX stock has given up its prior gain. Regenxbio shares were trading higher following Q1 financial results and after the company announced FDA acceptance and priority review of BLA for RGX-121.
